Advanced Search
Search Results
6557 total results found
219 - References
References Schizophrenia and related psychoses CHAPTER 1 Intramuscular clozapine Intramuscular clozapine is a short-term intervention for patients with a treatment- refractory psychotic disorder who refuse oral medication. It is always used with a view to co...
22 - Long term antipsychotic treatment
Long-term antipsychotic treatment 22 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Combined antipsychotics (antipsychotic polypharmacy) In psychiatric practice, prescriptions for combined antipsychotic medications are common1–3 and often long te...
220 - Optimising clozapine treatment
Optimising clozapine treatment
221 - Using clozapine alone
Using clozapine alone
222 - Clozapine augmentation
Clozapine augmentation 220 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Optimising clozapine treatment Using clozapine alone Target dose (dose is best adjusted according to patient tolerability and plasma level) ■ ■Average dose in UK is around ...
223 - References
References 222 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Other options include adding pimozide, olanzapine or sertindole. None is recommended: pimozide and sertindole have important cardiac toxicity and the addition of olanzapine is poorly s...
224 - Alternatives to clozapine
Alternatives to clozapine 226 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Alternatives to clozapine Clozapine has the strongest evidence for efficacy for schizophrenia that has proved refractory to adequate trials of standard antipsychotic med...
225 - Summary of alternatives to clozapine
Summary of alternatives to clozapine Schizophrenia and related psychoses CHAPTER 1 Summary of alternatives to clozapine Table 1.54 provides a summary of alternatives to clozapine in refractory schizophrenia. Table 1.54 Summary of alternatives to clozapine in ...
226 - References
References 230 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 References Millgate E, et al. Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis. Psychol Med 2022; 52:1–13. Yoshim...
227 - Restarting clozapine after a break in treatme
Restarting clozapine after a break in treatment 234 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Restarting clozapine after a break in treatment Interruptions in clozapine treatment are commonplace.1 Patients prescribed clozapine should be advi...
228 - References
References Schizophrenia and related psychoses CHAPTER 1 References John AP, et al. Rates and reasons for clozapine treatment interruptions: impact of the frequency of hematologic monitoring and cardiac adverse events. J Clin Psychopharmacol 2023; 43:233–238....
229 - Initiation of clozapine in the community
Initiation of clozapine in the community
23 - Adverse effects
Adverse effects Schizophrenia and related psychoses CHAPTER 1 monotherapy.24 Although the interpretation of such real-world findings is hindered by the issue of confounding by indication,25 there are perhaps several plausible explanations for improved efficac...
230 - Relative contraindications to community initi
Relative contraindications to community initiation
231 - Essential criteria for suitability for commun
Essential criteria for suitability for community initiation
232 - Initial work up
Initial work-up 236 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Initiation of clozapine in the community While in-patient initiation remains the main method of starting clozapine, community initiation is fairly common in many countries. The l...
233 - Mandatory blood monitoring and registration
Mandatory blood monitoring and registration
234 - Dosing
Dosing Schizophrenia and related psychoses CHAPTER 1 ■ ■Echocardiogram if clinically indicated. ■ ■Consider work-up for BEN where baseline neutrophil counts are low (see section on clozapine, neutropenia and lithium in this chapter). Genetic testing for BEN i...